XTL Biopharmaceuticals Ltd
XTLB
|
|
| |
|
| Trading Volume | 500 |
|
|
3.33 - 0.78 |
| Market Cap Full | $ 1.4B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 9.1% | 182.8% | 15.7% | -14.4% |
| Q2 | - | -26.9% | -28.5% | -35.9% |
| Q3 | - | -5.4% | 5.2% | -27% |
| Q4 | - | 16.4% | 4% | 3.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -17 | 3.5 | 229 | -20 | 17.9 | -15.5 | 25.6 | -5.4 | - | - | - | 5.3 |
| 2023 | |||||||||||
| 1.7 | 17.1 | -2.9 | -13.5 | 6.1 | -22.1 | -14.2 | 28.7 | -4.8 | -13.3 | 18.8 | -3.9 |
| 2022 | |||||||||||
| -9 | -5.6 | -0.4 | -7.2 | -16.8 | -16.9 | 7.2 | -9.2 | -25 | 16.2 | 3.1 | -13.5 |
| 2021 | |||||||||||
| 2.6 | 0.1 | 6.9 | 10.8 | -4.3 | 13 | -13.3 | 43.1 | -11.1 | -13.2 | -16.2 | -13.4 |
| 2020 | |||||||||||
| 21.3 | -16.3 | -12.3 | 3.4 | 10.3 | 18.7 | -0.6 | 7.6 | 11.8 | 21.1 | 8.3 | 21.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | 0.1 | 0.1 | 0 |
| Q2 | -0.1 | -0.1 | -0.2 | 0 |
| Q3 | -0 | 0 | 0 | 0 |
| Q4 | 0 | -0.1 | 0 | 0 |
| A | -0.28 | -0.1 | -0.1 | 0 |